651326-71-5

Basic information

• Product Name: 6-broMo-2,4-difluoro-3-(triMethylsilyl)benzaldehyde
• Synonyms: 6-broMo-2,4-difluoro-3-(triMethylsilyl)benzaldehyde
• CAS NO: 651326-71-5
• Molecular Formula: C₁₀H₁₁BrF₂OSi
• Molecular Weight: 293.1800464
• Mol File: 651326-71-5.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 6-broMo-2,4-difluoro-3-(triMethylsilyl)benzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 6-broMo-2,4-difluoro-3-(triMethylsilyl)benzaldehyde(651326-71-5)
• EPA Substance Registry System: 6-broMo-2,4-difluoro-3-(triMethylsilyl)benzaldehyde(651326-71-5)

Safety Data

• Hazardous Substances Data: 651326-71-5(Hazardous Substances Data)

Usage

Uses

Used in Organic Chemistry:
6-bromo-2,4-difluoro-3-(trimethylsilyl)benzaldehyde is used as a building block for the synthesis of various pharmaceuticals and agrochemicals. Its unique structure and reactivity make it a valuable intermediate for the production of complex organic molecules.
Used in Medicinal Chemistry:
6-bromo-2,4-difluoro-3-(trimethylsilyl)benzaldehyde may have potential applications in medicinal chemistry due to its versatile chemical properties. Its unique structure and reactivity can be utilized in the development of new drugs and therapeutic agents.
Used in Material Science:
6-bromo-2,4-difluoro-3-(trimethylsilyl)benzaldehyde may also have potential applications in material science. Its unique chemical properties can be harnessed to develop new materials with specific properties for various applications.

Upstream product

• 461-96-1 3,5-difluorobromobenzene 
• 184910-20-1 (4-bromo-2,6-difluoro-phenyl)-trimethyl-silane 

Relevant articles and documents

BIARYL DERIVATIVES AS YAP/TAZ-TEAD PROTEIN-PROTEIN INTERACTION INHIBITORS

The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof; (I) a method for manufacturing said compound, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition comprising said compound.

PENTACYCLIC OXEPINES AND DERIVATIVES THEREOF, COMPOSITIONS AND METHODS

The present invention provides a compound of the formula (I) wherein R1 is -H, -OH, -O(C1-C4 alkyl), -OCOC6H5, -OCO(C1-C6 alkyl), or -OSO2(C2-C6 alkyl); R0, R2 and R3 are each independently -H, -OH, -O(C1-C4 alkyl), -OCOC6H5, -OCO(C1-C6 alkyl), -OSO2(C2-C6 alkyl) or halo; R4 is 1-piperidinyl, 1-pyrrolidinyl, methyl-1-pyrrolidinyl, dimethyl-1-pyrrolidinyl, 4-morpholino, dimethylamino, diethylamino, diisopropylamino, or 1-hexamethyleneimino; n is 2 or 3 X is -S- or -HC=CH-; G is -O-, -S-, -SO-, SO2, or -N(R5)-, wherein R5 is -H or C1-C4 alkyl; and Y is -O-, -S-, -NH-, -NMe-, or -CH2-; or a pharmaceutically acceptable salt thereof; pharmaceutical compositions thereof, optionally in combination with estrogen and progestin; methods of inhibiting a disease associated with estrogen deprivation; and methods for inhibiting a disease associated with an aberrant physiological response to endogenous estrogen.